Aging Well with COPD through Geriatrics-Palliative Care
通过老年医学姑息治疗,让慢性阻塞性肺病患者安享晚年
基本信息
- 批准号:10263203
- 负责人:
- 金额:$ 24.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAgingAmericanAwardBiology of AgingCaringCause of DeathChronic Obstructive Airway DiseaseClinicClinical TrialsCommunitiesDataDecision MakingDevelopmentDisease OutcomeDoctor of PhilosophyEffectivenessElderlyElementsEpidemicEvaluationFamily CaregiverGeriatricsGerontologyGoalsHealthHealth Services AccessibilityHybridsInternationalInterventionKnowledgeLeadLifeLungMeasuresMentorsModelingNational Heart, Lung, and Blood InstituteNursesOncologyOutcomePalliative CareParticipantPatientsPersonal SatisfactionPhasePoliciesPositioning AttributeProceduresQuality of lifeRandomizedRandomized Controlled TrialsReach, Effectiveness, Adoption, Implementation, and MaintenanceResearchResearch PersonnelResearch PrioritySECTM1 geneSelf CareSocial isolationSocietiesSoutheastern United StatesSpecialistSurveysSymptomsTechniquesTelephoneTestingTrainingUnited StatesUnited States Agency for Healthcare Research and QualityUnited States National Institutes of HealthWorkacceptability and feasibilityaging brainbasecareer developmentclinical trial implementationcopingdisabilityeffectiveness implementation studyeffectiveness implementation trialend of lifeexperienceformative assessmentfunctional independenceimplementation facilitationimplementation scienceimprovedimproved outcomeinnovationleadership developmentmiddle agenovelpalliativepatient orientedpersonalized interventionprimary outcomeprogramsrecruitresearch and developmentrural areasecondary outcomeskillstelehealththeoriesunderserved area
项目摘要
Project Summary
The overall goal of this 5-year K76 resubmission is to support Anand S. Iyer, MD, MSPH to
become a leader in geriatrics-palliative care with the skills to improve the health and well-being
of older adults with chronic obstructive pulmonary disease (COPD). Dr. Iyer is a pulmonologist
and AHRQ-K12 COPD outcomes researcher. COPD is the third leading cause of death for older
Americans and accelerates loss of quality of life and functional independence. Research
priorities of the NIA identify a critical need for innovative geriatrics-palliative care models to
address unmet care needs for older adults, especially those from rural and underserved areas
where COPD is prevalent and palliative care access is limited. However, no geriatrics-
palliative care interventions have been systematically developed and tested for
community-dwelling older adults with COPD. Through this K76, Dr. Iyer will gain advanced
training in: 1) gerontology and geriatrics-palliative care; 2) clinical trials and implementation
science; and 3) leadership development in aging. To support his career development, Dr. Iyer
and his primary mentor, Cynthia Brown, MD, MSPH, have assembled a mentor team of experts
in geriatrics (Seth Landefeld, MD), palliative care-implementation science (Marie Bakitas, DNSc,
APRN), and COPD clinical trials (Mark Dransfield, MD). Dr. Iyer will seek advisement from
international leaders in aging biology (Steven Austad, PhD), lung aging (Victor Thannickal, MD),
geriatrics-palliative care (Christine Ritchie, MD, MSPH), and the aging brain in COPD (Karin
Hoth, PhD). Supported by an AHRQ-K12, Dr. Iyer developed, “EPIC: Early Palliative Care In
COPD”, a 6-month telehealth, palliative-nurse coach-led intervention for COPD patients and
their family caregivers. Preliminary feasibility results in middle-aged COPD patients and their
family caregivers are promising; however, it is not known how EPIC needs to be refined to meet
the needs of older COPD patients, especially the old-old. Guided by Baltes’ Theory of
Successful Aging, this K76 will: 1) Refine the geriatrics content of EPIC by engaging diverse
stakeholder groups of older COPD patients, family caregivers, clinicians, staff, and policy
leaders; and, 2) Conduct a hybrid type-1 effectiveness-implementation pilot randomized
controlled trial of Geri-EPIC plus usual COPD care versus usual COPD care alone to determine
feasibility and acceptability, to refine trial procedures, and to collect preliminary data on Life-
Space mobility to inform a fully-powered trial at the R01 level. Ultimately, this K76 will position
Dr. Iyer to be a leader in geriatrics-palliative care and patient-oriented aging research.
项目摘要
本次5年K76重新提交的总体目标是支持Anand S。Iyer,MD,MSPH至
成为老年病姑息治疗的领导者,掌握改善老年人健康和福祉的技能。
慢性阻塞性肺疾病(COPD)的老年人。艾耶医生是个肺病学家
和AHRQ-K12 COPD结局研究员。COPD是老年人死亡的第三大原因。
加速生活质量和功能独立性的丧失。研究
NIA的优先事项确定了对创新老年病姑息治疗模式的迫切需求,
解决老年人未得到满足的护理需求,特别是来自农村和服务不足地区的老年人
在慢性阻塞性肺病流行且姑息治疗有限的地方。不过,没有老年医学-
姑息治疗干预措施已经系统地开发和测试,
社区居住的COPD老年人。通过K76,Iyer博士将获得先进的
培训内容:1)老年学和老年病姑息治疗; 2)临床试验和实施
科学;和3)老龄化的领导力发展。为了支持他的职业发展,Iyer博士
和他的主要导师,辛西娅布朗,医学博士,MSPH,已经组建了一个专家导师团队
在老年病学(Seth兰德费尔德,医学博士)、姑息治疗实施科学(玛丽巴基塔斯,DNSc,
APRN)和COPD临床试验(Mark Dransfield,MD)。艾耶博士将寻求
衰老生物学的国际领导者(Steven Austad,博士),肺衰老(维克托Thannickal,医学博士),
老年人姑息治疗(克莉丝汀里奇,医学博士,MSPH)和慢性阻塞性肺病的大脑老化(卡琳
Hoth,PhD)。在AHRQ-K12的支持下,Iyer博士开发了“EPIC:早期姑息治疗”,
慢性阻塞性肺病”,一项为期6个月的远程保健,针对慢性阻塞性肺病患者的姑息性护士教练主导的干预,
他们的家庭照顾者。在中年COPD患者中的初步可行性结果及其
家庭照顾者是有前途的;然而,目前还不知道如何EPIC需要完善,以满足
老年COPD患者的需求,尤其是老年人。以巴尔特的
成功的老龄化,这K76将:1)通过参与不同的细化EPIC的老年医学内容
老年COPD患者、家庭护理人员、临床医生、工作人员和政策的利益相关者群体
领导者;以及2)进行混合型1有效性-实施试点,
一项Geri-EPIC加常规COPD治疗与常规COPD单独治疗的对照试验,以确定
可行性和可接受性,完善试验程序,并收集生命的初步数据-
空间机动性,为R 01级的全动力试验提供信息。最终,K76将定位于
博士Iyer将成为老年病姑息治疗和以病人为导向的老龄化研究的领导者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anand Sathyan Iyer其他文献
Anand Sathyan Iyer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anand Sathyan Iyer', 18)}}的其他基金
Aging Well with COPD through Geriatrics-Palliative Care
通过老年医学姑息治疗,让慢性阻塞性肺病患者安享晚年
- 批准号:
10044912 - 财政年份:2020
- 资助金额:
$ 24.28万 - 项目类别:
Aging Well with COPD through Geriatrics-Palliative Care
通过老年病学姑息治疗,让慢性阻塞性肺病患者安享晚年
- 批准号:
10673845 - 财政年份:2020
- 资助金额:
$ 24.28万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 24.28万 - 项目类别:
Operating Grants